亚洲 · 区域市场 · CNBC-TV18
Lupin launches HIV drug in US, secures eligibility for 180-day generic exclusivity
Lupin has launched Raltegravir Tablets USP, 600 mg, in the US after receiving FDA approval. The company is the exclusive first-to-file for the generic version of Merck's Isentress…
在 CNBC-TV18 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.cnbctv18.com)
